The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2026 | How can patients with early onset CRC be better identified and supported?
José Perea, MD, PhD, European University of Madrid, Madrid, Spain, discusses the importance of considering the unique needs of patients with early onset colorectal cancer, including psychosocial aspects, sexual activity, and fertility. A tailored approach to screening is needed for this subpopulation, as they are not adequately covered by general screening programs, and identifying individuals under 50 who are at risk of developing early onset cancer will be important. This interview took place at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
